Growth hormone-insuline-like growth factor-I system in pejerrey Odontesthes bonariensis (Atheriniformes)

Abstract

Using biotechnology to increase the growth rates of fish is likely to reduce production costs per unit of food. Among vertebrates, fish appear to occupy a unique position, when growth patterns are considered. With few exceptions, fish species tend to grow indeterminately, implying that size is never fixed. Both hyperplasia and hypertrophy contribute to post-larval muscle growth in fish. Growth hormone (GH) - Insulin-like Growth Factor I (IGF-I) is the most important growth axis in fish. Our experimental model, the pejerrey, Odontesthes bonariensis (Ateriniformes) is a South American inland water fish considered to be a promising species for intensive aquaculture. However, one major drawback to achieve this goal is its slow growth in captivity. In order to understand how growth is regulated in this species, our first objective was to characterized pejerrey GH- IGF-I axis. We first cloned and characterized pejerrey (pj) GH, IGF-I and the growth hormone receptors (GHRs) I and II. In addition to providing valuable data for evolutionary comparison of GH, investigation of GH action in teleosts is particularly important because of its potential application in aquaculture. GH can not only promote the somatic growth in fish but also lower dietary protein requirements. A prerequisite for providing sufficient amounts of GH for basic research and aquaculture application is a large-scale production of GH. For that purpose, recombinant pjGH was expressed in a bacterial system. Protocols for solubilization and proper folding were achieved. Activity of recombinant pjGH was assessed in fish by measuring the liver IGF-I response to different doses of GH. IGF-I transcript was measured in the liver after pjGHr in vivo stimulation by means of quantitative real-time PCR assays. A dose-dependent response of IGF-I mRNA was observed after pjGHr administration, and reached a 6 fold IGF-I maximum increase over control group when 2.5 µg pjGH /g-body weight were injected. Temporal analysis of hepatic IGF-I mRNA levels showed that administration of a single dose of pjGHr into juvenile pejerrey resulted in a significant increase (P<0.02) 9 hours post injection. These results demonstrates that recombinant pjGH could promote a dramatic response in liver, increasing the IGF-I mRNA level. We also study the effect of GH on muscle growth after oral administration. A significant association between GH doses and mean fiber area (MFA) was observed even with a caloric restrictive diet. MFA increased 3.7 µm² per each unit of GH supplied indicating that GH promoted white muscle hypertrophy. These preliminary data indicates that GH could be absorbed by the intestine in an active form and promote somatic growth.

growth; growth hormone; muscle hypertrophy; oral administration; recombinant protein

SYMPOSIUM: AQUATIC BIOTECHNOLOGY

Growth hormone-insuline-like growth factor-I system in pejerrey Odontesthes bonariensis (Atheriniformes)

S.E. Arranz^I; A. A. Sciara^I; P. Botta^I; P. Cerutti^III; M.Tobin^III; G.M. Somoza^II

^IInstituto de Biología Molecular y Celular de Rosario (IBR-CONICET) – Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Provincia de Santa Fe, Argentina

^IILaboratorio de Ictiofisiología y Acuicultura. IIB-INTECH (CONICET-Universidad de San Martín). Chascomús, Provincia de Buenos Aires. Argentina

^IIICátedra de Histología y Embriología-Facultad de Ciencias Veterinarias- Universidad Nacional de Rosario, Rosario, Provincia de Santa Fe, Argentina

ABSTRACT

Using biotechnology to increase the growth rates of fish is likely to reduce production costs per unit of food. Among vertebrates, fish appear to occupy a unique position, when growth patterns are considered. With few exceptions, fish species tend to grow indeterminately, implying that size is never fixed. Both hyperplasia and hypertrophy contribute to post-larval muscle growth in fish. Growth hormone (GH) - Insulin-like Growth Factor I (IGF-I) is the most important growth axis in fish. Our experimental model, the pejerrey, Odontesthes bonariensis (Ateriniformes) is a South American inland water fish considered to be a promising species for intensive aquaculture. However, one major drawback to achieve this goal is its slow growth in captivity. In order to understand how growth is regulated in this species, our first objective was to characterized pejerrey GH- IGF-I axis. We first cloned and characterized pejerrey (pj) GH, IGF-I and the growth hormone receptors (GHRs) I and II. In addition to providing valuable data for evolutionary comparison of GH, investigation of GH action in teleosts is particularly important because of its potential application in aquaculture. GH can not only promote the somatic growth in fish but also lower dietary protein requirements. A prerequisite for providing sufficient amounts of GH for basic research and aquaculture application is a large-scale production of GH. For that purpose, recombinant pjGH was expressed in a bacterial system. Protocols for solubilization and proper folding were achieved. Activity of recombinant pjGH was assessed in fish by measuring the liver IGF-I response to different doses of GH. IGF-I transcript was measured in the liver after pjGHr in vivo stimulation by means of quantitative real-time PCR assays. A dose-dependent response of IGF-I mRNA was observed after pjGHr administration, and reached a 6 fold IGF-I maximum increase over control group when 2.5 µg pjGH /g-body weight were injected. Temporal analysis of hepatic IGF-I mRNA levels showed that administration of a single dose of pjGHr into juvenile pejerrey resulted in a significant increase (P<0.02) 9 hours post injection. These results demonstrates that recombinant pjGH could promote a dramatic response in liver, increasing the IGF-I mRNA level. We also study the effect of GH on muscle growth after oral administration. A significant association between GH doses and mean fiber area (MFA) was observed even with a caloric restrictive diet. MFA increased 3.7 µm² per each unit of GH supplied indicating that GH promoted white muscle hypertrophy. These preliminary data indicates that GH could be absorbed by the intestine in an active form and promote somatic growth.

Key words: growth, growth hormone, muscle hypertrophy, oral administration, recombinant protein

Among vertebrates, fish appear to occupy a unique position, when growth patterns are considered. With few exceptions, fish species tend to grow indeterminately, implying that size is never fixed. Both hyperplasia and hypertrophy contribute to post larval muscle growth in fish.

Fish growth is strongly regulated by environmental factors, such as food availability, temperature and photoperiod. This process is mainly regulated by GH and IGF-I, both acting through membrane bound receptors, the GH receptor and IGF-I receptor respectively, and modulated by serum binding proteins (Duan & Xu 2005;Le Roith et al., 2005). GH has important metabolic effects. A strong link between energy status and circulating plasma GH levels exists in fish. The loss of hepatic GH receptors and circulating IGF-I levels is a characteristic feature of catabolic states.

Our experimental model, the pejerrey, Odontesthes bonariensis (Atheriniformes) is a South American inland water fish considered to be a promising species for intensive aquaculture. However, one major drawback to achieve this goal is its slow growth rate in captivity (Strüssmann et al., 1993). Although growth hormone, IGF-I and its receptors have been characterized in a number of fish there are no published data on the structure of these proteins in atherinid fish, except for Odontesthes argentinensis growth hormone (Marins et al., 2003).

During the last years the interest of the laboratory has been focused on the study of the growth physiology in pejerrey, not only from a basic point of view but also keeping attention to the potential application of the knowledge to increase the growth rates and allowing pejerrey aquaculture.

In this context, the goal of the present work was to summarize the findings on the characterization of the GH-IGF-I system in Odontesthes bonariensis and to produce a recombinant pejerrey GH for oral administration for growth rates improvement.

Growth hormone characterization and production of the recombinant protein

Growth hormone is an essential polypeptide required for normal growth and development of vertebrates (Forsyth & Wallis 2002). In addition to the well known effects of GH on somatic growth in vertebrates (Isaksson et al., 1987), it has also been shown to have roles in bony fish reproduction (Gomez et al., 1999;Le Gac et al. 1993) as well as in osmoregulation in euryhaline fish (Mancera et al.,2002).

The mature form of pejerrey growth hormone (pjGH) is a protein comprising a single polypeptide chain of 193 amino acids. It is found in the Proximal pars distalis of anterior pituitary gland (Sciara et al., 2006), like all GHs reported in vertebrates.

The homology of pjGH is high within members of Acanthopterigii superorder (from 75% in Pleuronectiformes to 85-92% in Perciformes and Beloniformes) but less homologous to members of Paracanpthoterigii and Protacanthopterigii superorders being the most divergent teleosts groups Cypriniformes and Siluriformes (53-66%). Pejerrey GH showed 28% identity with human GH (Sciara et al., 2006). Species differences in GH immunoreactivity are pronounced, and mammalian GH does not cross react in fish GH radioimmunoassay (Le Bail et al., 1993). Furthermore, the cross reactivity of polyclonal antibodies against fish GH is total with pituitary homogenates or GH preparations from fish of the same family, partial within the same order and very weak between orders. To overcome this limit, specific polyclonal antibodies against pjGH were produced (Sciara et al., 2006) as a prerequisite to assess the physiological role of GH in Atheriniformes.

The GH cDNA of various teleosts have been cloned and sequenced, and their recombinant GH has been shown to be potent in accelerating the growth rate of fish (Saito et al., 1985;Tsai et al., 1995). These findings make the use of GH in fish farming practical and promising because GH enhances appetite, feeding efficiency and growth rate (Donaldson et al., 1979).

Pejerrey recombinant GH was efficiently synthesized by Escherichia coli cells, although it exists in denatured form in inclusion bodies. Pejerrey GH, as all vertebrates GHs studied, has four cysteines that form two disulphide bridges. It was found that the large disulfide loop is essential for growth-promoting activity (Chen et al., 1992). This type of proteins undergoes conformational distortion, leading to aggregation and loss of function when they are express in bacterial systems that do not form disulfide bonds.

We have over-expressed recombinant growth hormone from pejerrey (Odontesthes bonariensis) in E. coli by a pET expression system. A 100-ml sample of pjGHr-producing E. coli produced 40 mg of inclusion bodies (dry weight) after 20 h induction by 20g/l lactose. The optimal solubilization conditions were 8 M urea and pH 12.5. Upon dissolution, the sample was diluted (1/10 dilution in 40 mM Tris-HCl pH 10.5), and the recombinant growth hormone subjected to a twostep equilibrium dialysis procedure (20 mM Tris-HCl pH 10.5 and 20 mM Tris-HCl pH 9 containing 50 mM L-arginine). Using this procedure, almost 100% hormone was recovered and no significant amounts of pjGHr were lost by precipitation of mis-folded polypeptides (Sciara et al, in press). Activity of pjGHr was tested in vivo by injecting juvenile fish with pjGHr and measuring IGF-I transcript by means of quantitative RT-PCR. Relatively high IGF-I mRNA levels are produce in the liver, which is the main endocrine source of serum IGF-I (Stewart & Rotwein 1996). Therefore, the liver was the organ of choice for an initial investigation of the GH dependency and temporal pattern of IGF mRNA expression. Our data clearly demonstrate that the level of IGF-I transcript in the pejerrey liver was significantly increased by recombinant pjGH administration in dose-dependent manner. Synthesis and degradation of IGF-I mRNA was shown to be fast in pejerrey. IGF-I basal levels were almost reached 6 hours after peak level (Sciara et al., in press). Remarkably, this dynamic was resembled in rainbow trout and tilapia in vivo and in cultured hepatocytes but pejerrey showed the fastest synthesis and degradation rates. Plasmatic IGF-I levels should be analysed. If this high clearance of IGF-I mRNA is related with a low plasmatic IGF-I level, an initial explanation of the endocrine reasons influencing pejerrey low somatic growth would arise.

Insulin-like growth factor-I

In mammals, somatic growth was thought to be controlled by pituitary GH and mediated by circulating IGF-I expressed exclusively by the liver. With the discovery that IGF-I is produced by most, if not all, tissues, the role of autocrine/paracrine IGF-I vs. the circulating form has been hotly debated (revised in (Le Roith et al., 2001). In teleosts it has been established that GH is the major activator of the IGF-I system, as it stimulates IGF-I gene expression in both liver and other tissues as well as it raises plasma IGF-I levels (Moriyama 1995). However, the question of whether the action of GH is direct or indirect has not yet been resolved.

IGF-I is a 70 amino acid hormone belonging to a conserved polypeptide family structurally related to proinsulin. Among other functions, IGF-I is involved in the regulation of proteins, lipids, carbohydrates, mineral metabolism in the cells, cell differentiation and proliferation, and ultimately in body growth (Moriyama et al., 2000). IGF-I by itself can promote somatic growth as it has been proved in carp (Zhang et al., 2006) and salmon (McCormickn et al., 1992) after administration.

Cloning and characterization of multiple forms of IGF-I mRNAs has been achieved for several teleosts including Salmoniformes (Duan 1997), Pleuronectiformes (Tanaka et al. 1998), Siluriformes (Clay et al, 2005), Cypriniformes (Zhang et al., 2006) and Perciformes (Vera Cruz et al., 2007), some of them encode different pro-IGF-I molecules which are finally processed into the same mature peptide. These prohormones were found to be produced by alternative mRNA splicing generating different sized carboxyterminal E domains. The predicted mature IGF-I protein from pejerrey has 68 amino acid residues with a calculated molecular mass of 7,4 kD that is codify by a single transcript (Sciara et al., in press). Although the liver always presents the highest levels of IGF-I expression in pejerrey fish, high IGF-I transcription was also detected in brain and posterior intestine (Sciara et al., 2008). The former could imply an elevate proliferation rate of neural precursors or neurogenesis (Ajo et al., 2003) a process that can also involve an inhibition of apoptosis (Chung et al., 2007). In this context, brain cell proliferation has been characterized in pejerrey brain, not only during larval development but also during adulthood (Strobl-Mazzulla et al. 2007). On the other hand, the physiology of intestine could manifest a difference in the physiology of intestine regions and their response to growth hormone. Differential absorption capacity of anterior and posterior intestine after GH chronic stimulation should be analyzed to give some answers to this question.

It was suggested that plasmatic IFG-I exerts a negative feedback effect over the hypothalamic control of GH production, as in mammals. It is also accepted that fasting abolishes the stimulatory action of GH on hepatic IGF-I synthesis and release (Duan 1998). Liver GH resistance is characterized by the loss of hepatic receptors and reduction of plasmatic IGF-I levels.

Research on GH axis in fish has yet to reach the level of mechanistic detail to understand its mode of action. Characterization of fish growth hormone receptors is a prerequisite for the study of mechanism governing the expression within each tissue and the signal pathways leading to the pleitropic effects of GH.

GH receptors and tissue distribution

Growth hormone exerts its functions interacting with a GH receptor on the cell membrane of the target tissues. GHR belongs to the cytokine receptor superfamily. It consists of a single extracellular domain involved in the GH-binding, a single transmembrane domain, and one intracellular domain with two conserved sequences or boxes. The extracellular domain of each receptor contains several pairs of conserved cysteine residues which interact by disulfide bonds, and a single cysteine necessary for the receptor dimerization. Intracellular boxes are important for signal transduction of the receptor. The proline-rich Box 1 region is the site of Janus kinase 2 (JAK2) binding and is essential for the signaling functions of GHR (VanderKuur et al., 1995). Box 2 contains about 15 amino acid (aa) residues and is believed to be involved in the internalization of the receptor (Govers et al., 1999).

The GHR cDNA sequences of more than 13 fish species have been reported. In nearly all the orders examined two subtypes of GHRs were found in a single fish species that clustered into different clades when the aa sequences were aligned. GHR cDNAs corresponding to distinct clades were characterized in zebrafish (Danio rerio, Cypriniformes (Di Prinzio et al., 2007), Gilhead sea bream (Sparus aurata, Perciformes (Calduch-Giner et al., 2003), Japanese eel (Anguilla japonica, Anguilliformes,(Ozaki et al., 2006)) and catfish (Silurus meridionalis, Siluriformes (Jiao et al., 2006)). One of the two subtypes of receptors characterized both in salmonids (Salmo salar, salmoniformes (Fukada et al. 2005)) and medaka (Oryzias latipes, Beloniformes (Fukamachi et al., 2005)) was reported to be a Somatolactin receptor (SLR). Phylogenetic analyses classified these SLRs as ortologs of the type I GHRs of other fish. Further studies are needed to unravel these intricacies. One clade (GHRI), containing 6 to 7 extracellular cysteine residues, is structurally more similar to the unique form reported in tetrapods. The other clade (GHRII), containing only 4 to 5 extracellular cysteine residues, is unique to teleosts and is structurally more divergent from the non-teleost GHRs (Fukamachi et al., 2006).

Functional differences were observed between the two subtypes receptors in black seabream using a number of reporter transcription assays in cultured eukaryotic cells (Jiao et al., 2006). The two subtypes possess differences in their signal transduction mechanisms and in their relative expression patterns. In vivo expression of sbGHR1 and sbGHR2 in seabream liver under various hormonal stimulations (cortisol, testosterone, and estradiol) also suggest a different regulation of each GHR. These functional differences probably explain and justify the preservation and coexistence of both GHR subtypes during teleostean evolution after genome duplication.

The co-existence of both GHR I and GHR II were also demonstrated in pejerrey (Odontesthes bonariensis, Atheriniformes (Botta et al., 2007), an Atherinid fish. Both receptor cDNAs could be detected in all tissues studied implying multiple physiological roles of GH, as it is suggested in mammalian species. The presence of GHRs in muscle and adipose tissue reflects the importance of GH in promoting growth and energy homeostasis (Perez-Sanchez, 2000). Moreover, GH seems to play a major role in the control of adipocyte lipolysis (Albalat et al., 2005). Transcripts for both types of receptor were also detected in the pituitary of pejerrey, suggesting a possible role in negative feedback on its own secretion. However, the GHRexpressing cells were not determined yet in the pituitary gland of pejerrey. GH has been shown to directly inhibit GH secretion in rainbow trout pituitary perfusion system (Agustsson & Bjornsson 2000). Recently, a novel intrapituitary feedback loop regulating GH release and GH expression has been identified in fish (for discussion see Canosa et al. 2007;Wong et al. 2006). Moreover, Zhou and colleagues (Zhou et al., 2004) identified the presence of one type of GHR (GHRI) in isolated carp somatrotropes. Since fish GHRs functional partitioning was reported (Saera-Vila et al. 2005), both receptors may be included for further studies.

Plasma GH levels show a clear seasonal pattern in fish in association to gonadal maturation, showing a correlation between GH and reproductive function (Björnsson et al., 1994; Gomez et al., 1999; Weber & Grau, 1999; Einarsdottir et al., 2002). In contrast, there is no clear correlation between serum GH levels and growth rates, especially in catabolic states. This fact may be explained by changes in GH binding protein (GHBP), the disponibility of GHR or the levels of IGF binding proteins (IGFBPs). To understand growth regulation is crucial to characterized and study not only GH secretion but GHRs and IGF-I expression. In vivo expression of pjGHRII in pejerrey liver under pjGHr stimulations was investigated (Botta et al. 2007). Although a significant increase of IGF-I expression in the liver was found 9 hours post injection, GH could not elicit any changes in pjGHRII gene expression in the fish liver during the same period of time suggesting that regulation of GHRII expression is more probably influence by nutritional status than to the plasma levels of GH.

Growth hormone oral administration

Studies were performed in order to determine whether recombinant pjGH could be absorbed by the intestine and promote growth in pejerrey. Pejerrey is a stomachless fish, so no special encapsulation was carried out in preliminary studies. It was reported that GH administration influences both hyperplasia and hypertrophy in white muscle fibers (Fauconneau et al., 1997). Oral doses of pjGHr were administrated once a week for 4 weeks at dosages of 2 (T1) and 20 (T2) µg pjGHr g^-1 fish body weight juvenile pejerrey (50 mg average weight). The effect of pjGHr on muscle hypertrophy (mean fiber area, MFA) and hyperplasia (percentage of fibers with an area less than 500 µm², <500) is shown in Table I. A significant association between GH doses and MFA (P=0.0002) and F<500 (P<0.0001) was observed. MFA increased 3.7 µm² per each unit of GH administrated, indicating that GH promoted white muscle hypertrophy. On the other hand, F<500 was reduced in 0.05% per each unit of GH which suggests that the hormone inhibit hyperplasia or recruitment of new fibers in O. bonariensis.

Although more detailed field studies on the growth promoting effect of recombinant pjGH by oral administration are needed in the future, these results clearly demonstrated that the hormone can be absorbed in the intestine and is biologically active.

Acknowledgements

This work was supported by ANPCYT (PICT Redes 00528) grant, Argentina.

• AGUSTSSON T and BJORNSSON BT Growth hormone inhibits growth hormone secretion from the rainbow trout pituitary in vitro. Comp Biochem Physiol C.Toxicol.Pharmacol. 126: 299-303, 2000.
• AJO R, CACICEDO L, NAVARRO C, and SANCHEZ-FRANCO F Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 144: 1086-1097, 2003.
• ALBALAT A, GOMEZ-REQUENI P, ROJAS P, MEDALE F, KAUSHIK S, VIANEN GJ, VAN DEN TG, GUTIERREZ J, PEREZ-SANCHEZ J, and NAVARRO I Nutritional and hormonal control of lipolysis in isolated gilthead seabream (Sparus aurata) adipocytes. Am.J.Physiol Regul.Integr.Comp Physiol 289: R259-R265, 2005.
• BOTTA P, SCIARA AA, and ARRANZ S. Identification and characterization of the growth hormone receptor in Pejerrey (Odontesthes bonariensis). In XLIII Reunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular, Mar del Plata, Buenos Aires, Argentina: 2007
• CALDUCH-GINER JA, MINGARRO M, VEGA-RUBIN dC, BOUJARD D, and PEREZ-SANCHEZ J Molecular cloning and characterization of gilthead sea bream (Sparus aurata) growth hormone receptor (GHR). Assessment of alternative splicing. Comp Biochem.Physiol B Biochem.Mol.Biol. 136: 1-13, 2003.
• CANOSA LF, CHANG JP, and PETER RE Neuroendocrine control of growth hormone in fish. Gen.Comp Endocrinol. 151: 1-26, 2007.
• CHEN XZ, SHAFER AW, YUN JS, LI YS, WAGNER TE, and KOPCHICK JJ Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. Mol.Endocrinol. 6: 598-606, 1992.
• CHUNG H, SEO S, MOON M, and PARK S IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4. J.Endocrinol. 194: 77-85, 2007.
• CLAY LA, WANG SY, WOLTERS WR, PETERSON BC, and WALDBIESER GC Molecular characterization of the insulin-like growth factor-I (IGF-I) gene in channel catfish (Ictalurus punctatus). Biochim.Biophys.Acta 1731: 139-148, 2005.
• DI PRINZIO C, BOTTA P, and ARRANZ S. Isolation and characterization of growth hormone receptors subtypes in zebrafish (Danio rerio). In XLIII Reunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular, Mar del Plata, Buenos Aires, Argentina: 2007
• DONALDSON E, FAGERLUND UHM, HIGGS DA, and MCBRIDE JR Hormonal enhancement of growth. In Hoar WS, RD, and Brett JR (Eds.) Fish physiolog. 455-597, 1979.
• DUAN C The insulin-like Growth Factor System and its Biological Actions in Fish. Amer.Zool. 37: 491-530, 1997.
• DUAN C Nutritional and developmental regulation of insulin-like growth factors in fish. J.Nutr. 128: 306S-314S, 1998.
• DUAN C and XU Q Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen.Comp Endocrinol. 142: 44-52, 2005.
• FAUCONNEAU B, CJ, LBPY, KF, and KSJ Control of skeletal muscle fibres and adipose cells size in the flesh of rainbow trout. J.Fish Biol. 50: 296-314, 1997.
• FORSYTH IA and WALLIS M Growth hormone and prolactin-molecular and functional evolution. J.Mammary.Gland.Biol.Neoplasia. 7: 291-312, 2002.
• FUKADA H, OZAKI Y, PIERCE AL, ADACHI S, YAMAUCHI K, HARA A, SWANSON P, and DICKHOFF WW Identification of the salmon somatolactin receptor, a new member of the cytokine receptor family. Endocrinology 146: 2354-2361, 2005.
• FUKAMACHI S, WAKAMATSU Y, and MITANI H Medaka double mutants for color interfere and leucophore free: characterization of the xanthophore-somatolactin relationship using the leucophore free gene. Dev.Genes Evol. 216: 152-157, 2006.
• FUKAMACHI S, YADA T, and MITANI H Medaka receptors for somatolactin and growth hormone: phylogenetic paradox among fish growth hormone receptors. Genetics 171: 1875-1883, 2005.
• GOMEZ JM, MOUROT B, FOSTIER A, and LE GAC F Growth hormone receptors in ovary and liver during gametogenesis in female rainbow trout (Oncorhynchus mykiss). J.Reprod.Fertil. 115: 275-285, 1999.
• GOVERS R, TEN BROEKE T, VAN KERKHOF P, SCHWARTZ AL, and STROUS GJ Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J. 18: 28-36, 1999.
• ISAKSSON OG, LINDAHL A, NILSSON A, and ISGAARD J Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr.Rev. 8: 426-438, 1987.
• JIAO B, HUANG X, CHAN CB, ZHANG L, WANG D, and CHENG CH The co-existence of two growth hormone receptors in teleost fish and their differential signal transduction, tissue distribution and hormonal regulation of expression in seabream. J.Mol.Endocrinol. 36: 23-40, 2006.
• LE BAIL PY, MOUROT B, ZOHAR Y, and PEREZ-SANCHEZ J Application of a sensitive radioimmunoassay for the measurement of grwth hormone in gilhead seabream, Sparus aurata, and other sparid fish. Can.J.Zool. 71: 1500-1505, 1993.
• LE GAC F, BLAISE O, FOSTIER A, LE BAIL PY, LOIR M, MOUROT B, and WEIL C Growth hormone (GH) and reproduction: a review. Fish Physiol.Biochem 11: 219-232, 1993.
• LE ROITH D, BONDY C, YAKAR S, LIU JL, and BUTLER A The somatomedin hypothesis: 2001. Endocr.Rev. 22: 53-74, 2001a
• MANCERA M J., CARRION L R., and DEL PILAR DEL RIO M Osmoregulatory action of PRL, GH, and cortisol in the gilthead seabream (Sparus aurata L). Gen.Comp Endocrinol. 129: 95-103, 2002.
• MARINS lF, LEVY JA, FOLCH JM, and SANCHEZ A A growth hormone-based phylogenetic analysis of euteleostean fishes including a representative species of the Atheriniformes Order, Odontesthes argentinensis. Genet.Mol.Biol. 26: 295-300, 2003.
• MCCORMICK SD, KELLEY KM, YOUNG G, NISHIOKA RS, and BERN HA Stimulation of coho salmon growth by insulin-like growth factor I. Gen.Comp Endocrinol. 86: 398-406, 1992.
• MORIYAMA S Increased plasma insulin-like growth factor-I (IGF-I) following oral and intraperitoneal administration of growth hormone to rainbow trout, Oncorhynchus mykiss. Growth Regul. 5: 164-167, 1995.
• MORIYAMA S, AYSON FG, and KAWAUCHI H Growth regulation by insulin-like growth factor-I in fish. Biosci.Biotechnol.Biochem. 64: 1553-1562, 2000.
• OZAKI Y, FUKADA H, KAZETO Y, ADACHI S, HARA A, and YAMAUCHI K Molecular cloning and characterization of growth hormone receptor and its homologue in the Japanese eel (Anguilla japonica). Comp Biochem.Physiol B Biochem.Mol.Biol. 143: 422-431, 2006.
• PEREZ-SANCHEZ J The involvement of growth in growth regulation, energy homeostasis and immune function in gilthead sea bream (Sparus aurata): a short review. Fish Physiol Biochem 22: 135-144, 2000.
• SAERA-VILA A, CALDUCH-GINER JA, and PEREZ-SANCHEZ J Duplication of growth hormone receptor (GHR) in fish genome: gene organization and transcriptional regulation of GHR type I and II in gilthead sea bream (Sparus aurata). Gen.Comp Endocrinol. 142: 193-203, 2005.
• SAITO A, SEKINE S, KOMATSU Y, SATO M, HIRANO T, and ITOH S Molecular cloning of eel growth hormone cDNA and its expression in Escherichia coli. Gene 73: 545-551, 1988.
• SCIARA AA, RUBIOLO JA, SOMOZA GM, and ARRANZ SE Molecular cloning, expression and immunological characterization of pejerrey (Odontesthes bonariensis) growth hormone. Comp Biochem.Physiol C.Toxicol.Pharmacol. 142: 284-292, 2006.
• SCIARA AA, SOMOZA GM, and ARRANZ SE. Insulin-like growth factor I of pejerrey, Odontesthes bonariensis: cDNA characterization, tissue distribution and expression profiles after growth hormone administration. J.Exp.Zool. In Press
• SEKINE S, MIZUKAMI T, NISHI T, KUWANA Y, SAITO A, SATO M, ITOH S, and KAWAUCHI H Cloning and expression of cDNA for salmon growth hormone in Escherichia coli. Proc.Natl.Acad.Sci.U.S.A 82: 4306-4310, 1985.
• STEWART CE and ROTWEIN P Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 76: 1005-1026, 1996.
• STROBL-MAZZULLA PH, FERNARDINO JI, GUILBUR LG,NÚÑEZ A, STRUSSMANN CA, PELLEGRINI E, KAH O, and SOMOZA GM. Relationship between brain cell proliferation and aromatase expression during thermolabile sex determination/differentiation period in pejerrey fish. 8th International Symposium on Reproductive Physiology of Fish 8th ISRPF 2007.June 3rd-8th, 2007 -Saint-Malo, France. 2007.
• STRÜSSMANN CA, CHON NB, TAKASHIMA F, and OSHIRO T Triploidy induction in an atherinid fish, the pejerrey (Odontesthes bonariensis). Prog.Fish-Cult. 55: 83-89, 1993.
• TANAKA M, TANIGUCHI T, YAMAMOTO I, SAKAGUCHI K, YOSHIZATO H, OHKUBO T, and NAKASHIMA K Gene and cDNA structures of flounder insulin-like growth factor-I (IGF-I): multiple mRNA species encode a single short mature IGF-I. DNA Cell Biol. 17: 859-868, 1998.
• TSAI HJ, LIN KL, KUO JC, and CHEN SW Highly efficient expression of fish growth hormone by Escherichia coli cells. Appl.Environ.Microbiol. 61: 4116-4119, 1995.
• VANDERKUUR JA, WANG X, ZHANG L, ALLEVATO G, BILLESTRUP N, and CARTER-SU C Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J.Biol.Chem. 270: 21738-21744, 1995.
• VERA CRUZ EM, BROWN CL, LUCKENBACH JA, PICHA ME, BOLIVAR RB, and BORSKI R Insulin-like growth factor-I cDNA cloning, gene expression and potential use as a growth rate indicator in Nile tilapia, Oreochromis niloticus. Aquaculture 251: 585-595, 2007.
• WONG AO, ZHOU H, JIANG Y, and KO WK Feedback regulation of growth hormone synthesis and secretion in fish and the emerging concept of intrapituitary feedback loop. Comp Biochem Physiol A Mol.Integr.Physiol 144: 284-305, 2006.
• WOOD AW, DUAN C, and BERN HA Insulin-like growth factor signaling in fish. Int.Rev.Cytol. 243: 215-285, 2005.
• ZHANG DC, HUANG YQ, SHAO YQ, and JIANG SG Molecular cloning, recombinant expression, and growth-promoting effect of mud carp (Cirrhinus molitorella) insulin-like growth factor-I. Gen.Comp Endocrinol. 148: 203-212, 2006.
• ZHOU H, KO WK, HO WK, STOJILKOVIC SS, and WONG AO Novel aspects of growth hormone (GH) autoregulation: GH-induced GH gene expression in grass carp pituitarycells through autocrine/paracrine mechanisms. Endocrinology 145: 4615-4628, 2004.

Publication Dates

• Publication in this collection
  10 June 2009
• Date of issue
  July 2008